Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4861 AL 4875

Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial

Forstmeier S, Maercker A, Savaskan E, Roth T.

Trials. 2015 Nov 17;16:526. doi: 10.1186/s13063-015-1043-0.

Donepezil-associated manic episode with psychotic features: a case report and review of the literature

Hategan A, Bourgeois JA.

Gen Hosp Psychiatry. 2016 Jan-Feb;38:115.e1-4. doi: 10.1016/j.genhosppsych.2015.09.004. Epub 2015 Sep 25.

Yoga and compassion meditation program improve quality of life and self-compassion in family caregivers of Alzheimer's disease patients: A randomized controlled trial

Danucalov MA, Kozasa EH, Afonso RF, Galduroz JC, Leite JR.

Geriatr Gerontol Int. 2017 Jan;17(1):85-91. doi: 10.1111/ggi.12675. Epub 2015 Dec 21.

Memory suppression in Alzheimer's disease

El Haj M.

Neurol Sci. 2016 Mar;37(3):337-43. doi: 10.1007/s10072-015-2441-5. Epub 2015 Dec 23.

Therapeutic strategies for Alzheimer's disease in clinical trials

Godyń J, Jończyk J, Panek D, Malawska B.

Pharmacol Rep. 2016 Feb;68(1):127-38. doi: 10.1016/j.pharep.2015.07.006. Epub 2015 Aug 5.

Functional connectivity increase in the default-mode network of patients with Alzheimer's disease after long-term treatment with Galantamine

Blautzik J, Keeser D, Paolini M, Kirsch V, Berman A, Coates U, Reiser M, Teipel SJ, Meindl T.

Eur Neuropsychopharmacol. 2016 Mar;26(3):602-13. doi: 10.1016/j.euroneuro.2015.12.006. Epub 2015 Dec 10.

The APOE genotype: modification of therapeutic responses in Alzheimer's disease

Hanson AJ, Craft S, Banks WA.

Curr Pharm Des. 2015;21(1):114-20. doi: 10.2174/1381612820666141020164222.

Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia

Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S.

J Alzheimers Dis. 2015;44(3):897-906. doi: 10.3233/JAD-141791.

Agitation and aggression in Alzheimer's disease: an update on pharmacological and psychosocial approaches to care

Gallagher D, Herrmann N.

Neurodegener Dis Manag. 2015;5(1):75-83. doi: 10.2217/nmt.14.46.

Demographic and Socioenvironmental Characteristics of Black and White Community-Dwelling Caregivers and Care Recipients' Behavioral and Psychological Symptoms of Dementia

Cothran FA, Farran CJ, Barnes LL, Whall AL, Redman RW, Struble LM, Dunkle RE, Fogg L.

Res Gerontol Nurs. 2015 Jul-Aug;8(4):179-87. doi: 10.3928/19404921-20150310-01. Epub 2015 Mar 10.

[Disclosing the diagnosis and guidance]

Bopp-Kistler I.

Ther Umsch. 2015 Apr;72(4):225-31. doi: 10.1024/0040-5930/a000669.

The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model

Puri V, Wang X, Vardigan JD, Kuduk SD, Uslaner JM.

Behav Brain Res. 2015;287:96-9. doi: 10.1016/j.bbr.2015.03.029. Epub 2015 Mar 20.

A pilot study of a new method of cognitive stimulation using abacus arithmetic in healthy and cognitively impaired elderly subjects

Matías-Guiu JA, Pérez-Martínez DA, Matías-Guiu J.

Neurologia. 2016 Jun;31(5):326-31. doi: 10.1016/j.nrl.2015.02.002. Epub 2015 Apr 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias